Ali Asif Sells $2.58 Million in Protagonist Therapeutics Stock
Published on 3/27/2026

AI Summary
Summarized by AI from the source belowAli Asif, a significant stakeholder at Protagonist Therapeutics (PTGX), sold shares worth $2.58 million. This transaction reflects a strategic move within the company, potentially impacting stock performance. As of the latest reporting, precise stock price and volume details were not disclosed, but insider sales can often signal market confidence or concerns. Such developments typically draw attention from investors watching PTGX's performance.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Earnings
Cardinal Health Raises Price Target After Positive Profit Guidance
Aug 11

Earnings
Hnit-Baltic Uab Announcement: Financial Performance Updates
Aug 11

Earnings
Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Aug 11

Markets
ATN International (ATNI) SVP Mary Mabey Sells $160,625 in Stock
Aug 11